192 related articles for article (PubMed ID: 19559348)
1. Magnetic resonance imaging of the small bowel with the true FISP sequence: intra- and interobserver agreement of enteroclysis and imaging without contrast material.
Wiarda BM; Horsthuis K; Dobben AC; Geenen RW; Heitbrink MA; Moolenaar W; Kuipers EJ; Stoker J
Clin Imaging; 2009; 33(4):267-73. PubMed ID: 19559348
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
[TBL] [Abstract][Full Text] [Related]
3. A combination of small bowel imaging methods: conventional enteroclysis with complementary magnetic resonance enteroclysis.
Akman C; Korman U; Oğüt G; Kuruğoğlu S; Urger E; Ulus S; Esen G; Tasci I
Clin Radiol; 2005 Jul; 60(7):778-86. PubMed ID: 15978889
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of the small bowel in Crohn's disease.
Frøkjaer JB; Larsen E; Steffensen E; Nielsen AH; Drewes AM
Scand J Gastroenterol; 2005 Jul; 40(7):832-42. PubMed ID: 16109660
[TBL] [Abstract][Full Text] [Related]
5. [Radiological assessment of small bowel obstructions: Value of conventional enteroclysis and dynamic MR-enteroclysis].
Rohr A; Rohr D; Kühbacher T; Schreiber S; Heller M; Reuter M
Rofo; 2002 Sep; 174(9):1158-64. PubMed ID: 12221576
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance enteroclysis in the diagnosis of small-intestinal Crohn's disease: diagnostic accuracy and inter- and intra-observer agreement.
Negaard A; Sandvik L; Mulahasanovic A; Berstad AE; Klöw NE
Acta Radiol; 2006 Dec; 47(10):1008-16. PubMed ID: 17135001
[TBL] [Abstract][Full Text] [Related]
7. Interobserver Agreement in MR Enterography for Diagnostic Assessment in Patients with Crohn's Disease.
Schleder S; Pawlik M; Wiggermann P; Ott C; Fichtner-Feigl S; Müller-Wille R; Stroszczynski C; Schreyer AG
Rofo; 2013 Sep; 184(10):992-7. PubMed ID: 23893750
[TBL] [Abstract][Full Text] [Related]
8. MR enteroclysis in refractory celiac disease: proposal and validation of a severity scoring system.
Van Weyenberg SJ; Meijerink MR; Jacobs MA; van Kuijk C; Mulder CJ; van Waesberghe JH
Radiology; 2011 Apr; 259(1):151-61. PubMed ID: 21330559
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations.
Malagò R; Manfredi R; Benini L; D'Alpaos G; Mucelli RP
Abdom Imaging; 2008; 33(6):669-75. PubMed ID: 18228087
[TBL] [Abstract][Full Text] [Related]
10. [MR enteroclysis for nuclear spin tomographic diagnosis of inflammatory bowel diseases with contrast enhancement].
Aschoff AJ; Zeitler H; Merkle EM; Reinshagen M; Brambs HJ; Rieber A
Rofo; 1997 Oct; 167(4):387-91. PubMed ID: 9417268
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
12. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
[TBL] [Abstract][Full Text] [Related]
13. MR enteroclysis using iron oxide particles (ferristene) as an endoluminal contrast agent: an open phase III trial.
Boraschi P; Braccini G; Gigoni R; Cartei F; Perri G
Magn Reson Imaging; 2004 Oct; 22(8):1085-95. PubMed ID: 15527995
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory bowel disease in children and adolescents: assessing the diagnostic performance and interreader agreement of magnetic resonance enterography compared to histopathology.
Wallihan DB; Towbin AJ; Denson LA; Salisbury S; Podberesky DJ
Acad Radiol; 2012 Jul; 19(7):819-26. PubMed ID: 22520509
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease.
Amzallag-Bellenger E; Oudjit A; Ruiz A; Cadiot G; Soyer PA; Hoeffel CC
Radiographics; 2012; 32(5):1423-44. PubMed ID: 22977028
[TBL] [Abstract][Full Text] [Related]
16. MRI of small bowel Crohn's disease: determining the reproducibility of bowel wall gadolinium enhancement measurements.
Sharman A; Zealley IA; Greenhalgh R; Bassett P; Taylor SA
Eur Radiol; 2009 Aug; 19(8):1960-7. PubMed ID: 19308416
[TBL] [Abstract][Full Text] [Related]
17. Measurement of MRI enhancement kinetics for evaluation of inflammatory activity in Crohn's disease.
Röttgen R; Grandke T; Grieser C; Lehmkuhl L; Hamm B; Lüdemann L
Clin Imaging; 2010; 34(1):29-35. PubMed ID: 20122516
[TBL] [Abstract][Full Text] [Related]
18. MR enteroclysis in the diagnosis of small-bowel neoplasms.
Van Weyenberg SJ; Meijerink MR; Jacobs MA; Van der Peet DL; Van Kuijk C; Mulder CJ; Van Waesberghe JH
Radiology; 2010 Mar; 254(3):765-73. PubMed ID: 20177091
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of time-intensity curves in ductal carcinoma in situ (DCIS) and mastopathy obtained using dynamic contrast-enhanced magnetic resonance imaging.
Nishiura M; Yasuhiro T; Murase K
Magn Reson Imaging; 2011 Jan; 29(1):99-105. PubMed ID: 20833496
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional contrast-enhanced hepatic MR imaging: comparison between a centric technique and a linear approach with partial Fourier along both slice and phase directions.
Kim KA; Herigault G; Kim MJ; Chung YE; Hong HS; Choi SY
J Magn Reson Imaging; 2011 Jan; 33(1):160-6. PubMed ID: 21182134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
